ALLYDONE® Patches
Mild to Severe Alzheimer's Disease
ApprovedCommercial (Japan, 2022)
Key Facts
Indication
Mild to Severe Alzheimer's Disease
Phase
Approved
Status
Commercial (Japan, 2022)
Company
About Teikoku Seiyaku
A 170-year-old Japanese pioneer in transdermal hydrogel patches, developing innovative pain management and systemic drug delivery solutions.
View full company profile